Prognosis of untreated patients with idiopathic membranous nephropathy

[1]  J. Cameron.  Membranous nephropathy in childhood and its treatment , 1990, Pediatric Nephrology.

[2]  R. Edelman,et al.  A preliminary report comparing magnetic resonance coronary angiography with conventional angiography. , 1993, The New England journal of medicine.

[3]  R. Rifkin,et al.  Screening for latent coronary artery disease by fluoroscopic detection of calcium in the coronary arteries. , 1993, The American journal of cardiology.

[4]  S. Arai,et al.  The impact of FK506 on graft coronary disease of rat cardiac allograft--a comparison with cyclosporine. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[5]  P. Kincaid‐smith,et al.  Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis. , 1992, Clinical nephrology.

[6]  B. Kasiske,et al.  Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory? , 1992, Kidney international. Supplement.

[7]  A. Tzakis,et al.  FK 506 in the management of transplant-related nephrotic syndrome and steroid-resistant nephrotic syndrome. , 1991, Transplantation proceedings.

[8]  R. Glassock.  The therapy of idiopathic membranous glomerulonephritis. , 1991, Seminars in nephrology.

[9]  R. W. James,et al.  Toxicologic evaluation of FK 506. , 1990, Transplantation proceedings.

[10]  H. Shimada,et al.  Effects of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dogs. , 1989, Transplantation.

[11]  C. Ohlschlegel,et al.  Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. , 1989, Clinical nephrology.

[12]  C. Cardella,et al.  A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. , 1989, The New England journal of medicine.

[13]  P. S. Williams,et al.  Immunosuppression can arrest progressive renal failure due to idiopathic membranous glomerulonephritis. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  A. Woodroffe,et al.  The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy. , 1988, Clinical nephrology.

[15]  A. Rees,et al.  PREDNISOLONE AND CHLORAMBUCIL TREATMENT IN IDIOPATHIC MEMBRANOUS NEPHROPATHY WITH DETERIORATING RENAL FUNCTION , 1988, The Lancet.

[16]  J. Velosa,et al.  Idiopathic membranous nephropathy: the natural history of untreated patients. , 1988, Kidney international.

[17]  M. Weintraub,et al.  Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. , 1987, The Journal of clinical investigation.

[18]  K. Jindal,et al.  A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis. , 1987, Kidney international.

[19]  S. Garattini,et al.  What is the basis for the use of steroids in the treatment of idiopathic membranous nephropathy? , 1987, Nephron.

[20]  S. Mendoza,et al.  Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents. , 1987, Nephron.

[21]  E. Honkanen.  Survival in idiopathic membranous glomerulonephritis. , 1986, Clinical nephrology.

[22]  H. Kida,et al.  Long-term prognosis of membranous nephropathy. , 1986, Clinical nephrology.

[23]  R. Wilkinson,et al.  The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. , 1984, Clinical nephrology.

[24]  C. Ponticelli,et al.  A Randomized Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy , 1984 .

[25]  D. Petitti,et al.  Membranous nephropathy: predictors of terminal renal failure. , 1984, Nephron.

[26]  N. V. Nikiforova,et al.  High-density lipoprotein cholesterol in patients with untreated and treated nephrotic syndrome. , 1984, Nephron.

[27]  J. Goldberg,et al.  Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. , 1981, The New England journal of medicine.

[28]  N. Mallick,et al.  The nephrotic syndrome and ischaemic heart disease. , 1981, Nephron.

[29]  V. Wass,et al.  Cardiovascular disease and the nephrotic syndrome: the other side of the coin. , 1981, Nephron.

[30]  R. Doll,et al.  Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. , 1979, British medical journal.

[31]  M. Lopes-Virella,et al.  Urinary high density lipoprotein in minimal change glomerular disease and chronic glomerulopathies. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[32]  H. L. Barnett.  Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the international study of kidney disease in children. , 1979, The Journal of pediatrics.

[33]  D. Droz,et al.  Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients. , 1979, The American journal of medicine.

[34]  R. Ross,et al.  ROLE OF THE PLATELET IN ATHEROGENESIS * , 1976, Annals of the New York Academy of Sciences.

[35]  C. F. Anderson,et al.  Controlled trial of cyclophosphamide in idiopathic membranous nephropathy. , 1974, Kidney international.

[36]  J. Peto,et al.  Asymptotically Efficient Rank Invariant Test Procedures , 1972 .